Isatuximab subcutaneous by on-body injector in Relapsed/Refractory multiple myeloma in the Phase 3 iraklia study: Effect of body weight on pharmacokinetics and clinical outcome
Por:
Lu, J, Oriol, A, Berkovits, A, Spencer, A, Gomez, C, Li, CR, Cerchione, C, Li, F, Schjesvold, F, Parmar, G, Spicka, I, Hus, M, Custidiano, MD, Dimopoulos, M, Rajnics, P, Besisik, SK, Ailawadhi, S, Ling, SL, Hungria, V, Leleu, X, Teisserenc, FS, Stefanova-Urena, M, Zhang, RC, Koch, V and Semiond, D
Publicada:
1 dic 2025
Ahead of Print:
1 dic 2025
Resumen:
Filiaciones:
Lu, J:
Peking Univ, Beijing, Peoples R China
:
Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain
Berkovits, A:
Inmunocel, Santiago, Chile
Spencer, A:
Monash Univ, Melbourne, Australia
Gomez, C:
Norfolk & Norwich Univ Hosp, Norwich, England
Li, CR:
Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Peoples R China
Cerchione, C:
Univ Bologna, Bologna, Italy
Li, F:
Harbin Med Univ, Harbin, Peoples R China
Schjesvold, F:
Oslo Myeloma Ctr, Oslo, Norway
Parmar, G:
Illawarra Canc Care Ctr, Wollongong, NSW, Australia
Spicka, I:
Charles Univ Prague, Prague, Czech Republic
Hus, M:
Univ Lublin, Lublin, Poland
Custidiano, MD:
Inst Alexander Fleming, Buenos Aires, Argentina
Dimopoulos, M:
Natl & Kapodistrian Univ Athens, Athens, Greece
Rajnics, P:
Mbr Kap Teaching Hosp, Kaposvar, Hungary
Besisik, SK:
Istanbul Univ, Istanbul, Turkiye
Ailawadhi, S:
Mayo Clin, Jacksonville, FL USA
Ling, SL:
Sydney Adventist Hosp, Wahroonga, NSW, Australia
Hungria, V:
Irmandade Santa Casa Misericordia Sao Paulo, Sao Paulo, Brazil
Leleu, X:
Ctr Hosp Univ Poitiers, Poitiers, France
Teisserenc, FS:
Sanofi, Vitry Sur Seine, France
Stefanova-Urena, M:
Sanofi, Morristown, NJ USA
Zhang, RC:
Sanofi, Morristown, NJ USA
Koch, V:
Sanofi, Vitry Sur Seine, France
Semiond, D:
Sanofi, Cambridge, MA USA
|